Protein-protein interactions as therapeutic targets in neuropsychopharmacology.
Reilly
Matthew T
MT
Department of Pharmacology and Toxicology, Program in Chemical Biology and Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA.
Cunningham
Kathryn A
KA
Natarajan
Amarnath
A
D000818:Animals; D050976:Basic-Leucine Zipper Transcription Factors / Q000037:antagonists & inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy; D002352:Carrier Proteins / Q000037:antagonists & inhibitors; D002493:Central Nervous System Diseases / Q000188:drug therapy; D016503:Drug Delivery Systems / Q000379:methods*; D051856:Fanconi Anemia Complementation Group Proteins / Q000037:antagonists & inhibitors; D005260:Female; D000072233:Homer Scaffolding Proteins; D006801:Humans; D009480:Neuropharmacology / Q000379:methods*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D054730:Protein Interaction Domains and Motifs / Q000187:drug effects*; D011600:Psychopharmacology / Q000379:methods*; D051381:Rats; D017981:Receptors, Neurotransmitter / Q000819:agonists / Q000037:antagonists & inhibitors; D025521:Tumor Suppressor Proteins / Q000037:antagonists & inhibitors; D043222:Ubiquitin Thiolesterase / Q000037:antagonists & inhibitors
C102108:BACH1 protein, human; C400134:BAP1 protein, human; D050976:Basic-Leucine Zipper Transcription Factors; D002352:Carrier Proteins; D051856:Fanconi Anemia Complementation Group Proteins; D000072233:Homer Scaffolding Proteins; D017981:Receptors, Neurotransmitter; D025521:Tumor Suppressor Proteins; D043222:Ubiquitin Thiolesterase